WuXi AppTec’s 100% Stock Rally Defies Geopolitical Headwinds

The Pentagon’s designation of WuXi AppTec Co. as a Chinese military company may have prompted some US clients to pull back, but investors are still piling into the stock betting the firm will remain central to the global supply of obesity, cancer and other drugs.

By Amber Tong and Sangmi Cha